179 related articles for article (PubMed ID: 8579968)
21. Inclusion body myositis--a review.
Vogel H
Adv Anat Pathol; 1998 May; 5(3):164-9. PubMed ID: 9868522
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
Askanas V; Engel WK; Nogalska A
J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
[TBL] [Abstract][Full Text] [Related]
23. Sporadic inclusion-body myositis: A degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy.
Askanas V; Engel WK; Nogalska A
Biochim Biophys Acta; 2015 Apr; 1852(4):633-43. PubMed ID: 25241263
[TBL] [Abstract][Full Text] [Related]
24. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers.
Fratta P; Engel WK; Van Leeuwen FW; Hol EM; Vattemi G; Askanas V
Neurology; 2004 Sep; 63(6):1114-7. PubMed ID: 15452314
[TBL] [Abstract][Full Text] [Related]
25. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
Fidziańska A; Glinka Z
Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
[TBL] [Abstract][Full Text] [Related]
26. Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.
Nogalska A; D'Agostino C; Engel WK; Cacciottolo M; Asada S; Mori K; Askanas V
J Neuropathol Exp Neurol; 2015 Jun; 74(6):538-46. PubMed ID: 25978849
[TBL] [Abstract][Full Text] [Related]
27. Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.
Weihl CC; Pestronk A
Curr Opin Neurol; 2010 Oct; 23(5):482-8. PubMed ID: 20664349
[TBL] [Abstract][Full Text] [Related]
28. Inclusion body myositis (IBM).
Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
[TBL] [Abstract][Full Text] [Related]
29. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J
Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914
[TBL] [Abstract][Full Text] [Related]
30. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
Askanas V; Engel WK
Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
[TBL] [Abstract][Full Text] [Related]
31. Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle.
Jaworska-Wilczynska M; Wilczynski GM; Engel WK; Strickland DK; Weisgraber KH; Askanas V
Neurology; 2002 Feb; 58(3):438-45. PubMed ID: 11839845
[TBL] [Abstract][Full Text] [Related]
32. Inclusion body myositis: new insights into pathogenesis.
Garlepp MJ; Mastaglia FL
Curr Opin Rheumatol; 2008 Nov; 20(6):662-8. PubMed ID: 18946325
[TBL] [Abstract][Full Text] [Related]
33. BACE1 and BACE2 in pathologic and normal human muscle.
Vattemi G; Engel WK; McFerrin J; Pastorino L; Buxbaum JD; Askanas V
Exp Neurol; 2003 Feb; 179(2):150-8. PubMed ID: 12618121
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
[TBL] [Abstract][Full Text] [Related]
35. Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study.
Bastian A; Goebel HH
Rom J Intern Med; 2010; 48(4):377-84. PubMed ID: 21528768
[TBL] [Abstract][Full Text] [Related]
36. beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle.
Sarkozi E; Askanas V; Johnson SA; Engel WK; Alvarez RB
Neuroreport; 1993 Jun; 4(6):815-8. PubMed ID: 8394158
[TBL] [Abstract][Full Text] [Related]
37. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
Wójcik S; Engel WK; McFerrin J; Askanas V
Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.
Fukuchi K; Pham D; Hart M; Li L; Lindsey JR
Am J Pathol; 1998 Dec; 153(6):1687-93. PubMed ID: 9846958
[TBL] [Abstract][Full Text] [Related]
39. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers.
Fratta P; Engel WK; McFerrin J; Davies KJ; Lin SW; Askanas V
Am J Pathol; 2005 Aug; 167(2):517-26. PubMed ID: 16049336
[TBL] [Abstract][Full Text] [Related]
40. Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.
Kannanayakal TJ; Mendell JR; Kuret J
Neurosci Lett; 2008 Jan; 431(2):141-5. PubMed ID: 18191026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
